A New Era in Veterinary Regenerative Medicine: How SMS Cells Are Transforming Animal Health
Small Mobile Stem (SMS) cells are emerging as a groundbreaking advancement in regenerative medicine for animals—and SMSbiotech’s new white paper highlights exactly why. Unlike traditional stem cell therapies that rely on cell differentiation, SMS cells activate the body’s own repair mechanisms, enabling natural, fully compatible tissue regeneration with no adverse reactions. Scalable, stable, and delivered as an off-the-shelf therapy, SMS cells have shown rapid recovery in animal models of COPD, osteoarthritis, and chronic wounds, often after just a single treatment.
With patented large-scale manufacturing, extraordinary cell stability, and strong preclinical results, SMS cells represent a transformative platform poised to reshape veterinary care. This article breaks down the key insights from the white paper and explores how SMS cell therapy is setting a new standard for safe, effective, and accessible regenerative treatments in animal health.
Dive deeper into the science, the data, and the clinical potential of SMS cells in veterinary medicine.
Download the SMS Cell Therapy for Animal Health White Paper
